Metagenomics Market | Exclusive revenue report and

Wilmington, Delaware, U.S., Oct. 11, 2022 (GLOBE NEWSWIRE) — Transparency Market Research Inc.Next-generation metagenomic sequencing (NGS) has demonstrated enormous potential in the diagnosis of neuro-infectious diseases, particularly CNS infectious diseases, on which companies are keenly capitalizing. Advancements in NGS platforms and bioinformatics tools are creating new revenue streams for major players in the metagenomics market. The metagenomics market is expected to reach US$6.1 billion by 2030

The study analysts have observed that growing concerns over infectious diseases on human health will influence the dynamics of the future market demand for metagenomics. It should be noted that the application of metagenomics-enabled microbial surveillance to reduce the frequency of outbreaks in the future has opened up new growth prospects for the metagenomics market players.

Get an exclusive sample PDF copy of Metagenomics Market

The demand for metagenomics tools in food microbiology is abundant. TMR analysts in the study found that the food and beverage segment is highly lucrative. The use of next-generation sequencing to improve food safety will increase and broaden the horizon of lucrative demand in the food and beverage industry.

Main results of Metagenomics Market Research

  • R&D in Bioinformatics youoh Help Expand revenue streams: Advances in bioinformatics tools are gradually simplifying the reading of metagenomic data. These have vehemently fueled the advancements in microbial ecology and hence have driven the expansion of the metagenomics market. A host of new tools are being adopted to enrich bioinformatics analyzes in metagenomics, and thus have boosted the market prospects. Their plentiful demand among healthcare businesses for the diagnosis of neuro-infectious diseases will expand the lucrative avenues during the forecast period 2020-2030.
  • The growing use of metagenomic sequencing in disease diagnosis creates a lucrative avenue: Growing demand for metagenomic sequencing for drug discovery and disease diagnosis will propel revenue streams for companies in the metagenomics market. Use is increasing in infectious disease management, where next-generation metagenomic sequencing holds incredible potential for identifying pathogens and assessing their diversity. It should be noted that the use of technologies has grown in clinical diagnostics. Additionally, end-to-end microbiome platforms by next-generation sequencing service providers have unlocked huge revenue potential for metagenomics market players, the study authors observed.
  • Companies are exploring new bioinformatics technologies to meet demand Of Soil Health Assessment: Microbial ecologists are exploiting shotgun metagenomics to assess soil microbial diversity. In addition, flow cytometry-enabled mini-metagenomics is expected to gain traction in understanding forest floor microbial diversity, thereby providing additional opportunities for metagenomics market players.

Ask for references –

Metagenomics market: main drivers

  • The need for advanced technologies for the rapid diagnosis of neuroinfectious diseases is a key factor underpinning the market outlook for next-generation metagenomic sequencing technologies. The incidence and burden of infectious diseases in general is a key driver for investments in metagenomics market activities.
  • Growing concerns of climate change on soil biodiversity is a key driver for the application of soil metagenome projects, thereby increasing the metagenomics market size.

Metagenomics market: regional growth dynamics

  • North America held a major share of the global metagenomics market in 2019. The region is rife with opportunities with rapid adoption of various metagenomics sequencing platforms. Extensive research on finding new diagnostic strategies for the detection and characterization of SARS-CoV-2 has boosted research spending in the region.
  • Europe was another lucrative market in 2019, accounting for a key market share. The increased adoption of bioinformatics tools has fueled growth opportunities. Additionally, the relentless research on microbial ecology and soil diversity has catalyzed the application of metagenomics, thereby enhancing the revenue potential of the regional market.

Make a survey before buying –

Metagenomics Market: Key Players

Most of the key players in the metagenomics market are relying on expanding their product portfolio and aiming to strengthen their position in different geographies.

Some of the major ones are Computomics GmbH, PerkinElmer, Inc., Microsynth AG, Zymo Research, Eurofins Scientific, Arc Bio, LLC., Takara Bio, Inc., Novogene Co., Ltd., Promega Corporation, Illumina, Inc., QIAGEN and Thermo Fisher Scientific, Inc.

Metagenomics market segmentation

type of product

  • Instruments
  • Kits and reagents
  • Software and services


  • 16S sequencing
  • Whole genome sequencing
  • Shotgun sequencing
  • Others


  • Ecology & Environment
  • Clinical diagnosis
  • drug discovery
  • Biotechnology
  • Food and drinks
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Modernization of healthcare in terms of infrastructure and services has pushed the healthcare industry to new heights, stay updated with Last Health Care Research Reports by Transparency Market Research:

Mouse Model Generation Market: The global mouse model generation market is expected to reach over US$918.4 million by 2031 at a CAGR of 8.1% from 2022 to 2031.

Cancer Biomarkers Market: The global cancer biomarkers market is expected to reach over US$31.4 billion by 2031 at a CAGR of 9.9% from 2022 to 2031.

Analytical Standards Market: The global analytical standards market is expected to reach over US$2.29 billion by the end of 2031 at a CAGR of 6.7% from 2022 to 2031.

Mouse Model Technology Market: The global mouse model technology market is expected to reach US$3.2 billion by 2031 at a CAGR of 7.4% from 2022 to 2031.

Soft Tissue Allograft Market: The global soft tissue allograft market is expected to reach over US$6.3 billion by the end of 2031 at a CAGR of 5.5% from 2022 to 2031.

Animal Genetics Market: The global animal genetics market is expected to reach over US$9.1 billion by the end of 2031 at a CAGR of 6.7% from 2022 to 2031.

Transplant Drug Surveillance Testing Market: The global transplant drug surveillance testing market is expected to reach over US$542 million by the end of 2031 at a CAGR of 11.0% from 2022 to 2031.

Surgical Retractors Market: The global surgical retractors market is expected to grow at a CAGR of around 5% during the forecast period 2020-2030.

About Transparency Market Research

Transparency Market Research, a global market research firm registered in Wilmington, Delaware, USA, provides personalized research and advisory services. Our proprietary blend of quantitative forecasting and trend analysis delivers forward-looking insights to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive datasets and research material for trade reports.

For more information on research on leading industries, visit our YouTube channel and click subscribe for future update –


Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
E-mail: [email protected]

Comments are closed.